$1.97
-0.02-1.01%
al cierre: -
$2.02
0.052.54%
After hour: Oct 31, 8:56 AM EDT
Comments
Loading...
Informe de interés en corto
El interés corto en Innate Pharma SA (NASDAQ:IPHA) ha aumentado durante el último período de informe, aumentando en aumento desde 48.69K hasta 53.08K. Esto representa el 0.07% de las acciones disponibles públicamente de la empresa.
El interés en corto en Innate Pharma Corp (XNAS:IPHA) disminuyó durante el último período de informe, cayendo de 280,30 millones a 275,20 millones. Esto hizo que el 1,17 % de las acciones disponibles públicamente de la empresa se pusieran en corto.
Basado en el volumen promedio reciente de 12.68K acciones negociadas por día, tomaría 4.19 día(s) para que los poseedores de este interés corto cierren sus posiciones sin impulsar bruscamente el precio de las acciones.
Interés en corto
53.08K
Interés en corto %
0.07%
Días para cubrir
4.19
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
IPHA | Innate Pharma S.A. ADS | 10/15/2025 | 10/24/2025 | 0.07% | 81,437,908 | 53,076 | 12,675 | 4.19 | |
IPHA | Innate Pharma S.A. ADS | 09/30/2025 | 10/09/2025 | 0.06% | 81,437,908 | 48,691 | 28,356 | 1.72 | |
IPHA | Innate Pharma S.A. ADS | 09/15/2025 | 09/24/2025 | 0.06% | 81,437,908 | 46,368 | 12,466 | 3.72 | |
IPHA | Innate Pharma S.A. ADS | 08/29/2025 | 09/10/2025 | 0.06% | 81,437,908 | 49,023 | 7,861 | 6.24 | |
IPHA | Innate Pharma S.A. ADS | 08/15/2025 | 08/26/2025 | 0.06% | 81,437,258 | 52,047 | 5,223 | 9.96 | |
IPHA | Innate Pharma S.A. ADS | 07/31/2025 | 08/11/2025 | 0.09% | 81,437,258 | 70,228 | 18,096 | 3.88 | |
IPHA | Innate Pharma S.A. ADS | 07/15/2025 | 07/24/2025 | 0.06% | 81,435,958 | 52,005 | 5,632 | 9.23 | |
IPHA | Innate Pharma S.A. ADS | 06/30/2025 | 07/10/2025 | 0.07% | 81,435,958 | 60,667 | 15,688 | 3.87 | |
IPHA | Innate Pharma S.A. ADS | 06/13/2025 | 06/25/2025 | 0.06% | 81,428,808 | 51,456 | 7,944 | 6.48 | |
IPHA | Innate Pharma S.A. ADS | 05/30/2025 | 06/10/2025 | 0.07% | 81,428,808 | 56,217 | 10,655 | 5.28 | |
IPHA | Innate Pharma S.A. ADS | 05/15/2025 | 05/27/2025 | 0.08% | 81,428,808 | 65,673 | 40,465 | 1.62 | |
IPHA | Innate Pharma S.A. ADS | 04/30/2025 | 05/09/2025 | 0.66% | 56,935,283 | 376,067 | 21,425 | 17.55 | |
IPHA | Innate Pharma S.A. ADS | 04/15/2025 | 04/25/2025 | 0.79% | 48,603,971 | 386,047 | 36,247 | 10.65 | |
IPHA | Innate Pharma S.A. ADS | 03/31/2025 | 04/09/2025 | 0.84% | 48,589,896 | 407,251 | 15,652 | 26.02 | |
IPHA | Innate Pharma S.A. ADS | 03/14/2025 | 03/25/2025 | 0.86% | 48,589,896 | 417,095 | 17,014 | 24.51 | |
IPHA | Innate Pharma S.A. ADS | 02/28/2025 | 03/11/2025 | 0.95% | 48,589,896 | 461,383 | 1,435,456 | 1 | |
IPHA | Innate Pharma S.A. ADS | 02/14/2025 | 02/26/2025 | 0.32% | 48,589,896 | 154,180 | 25,274 | 6.1 | |
IPHA | Innate Pharma S.A. ADS | 01/31/2025 | 02/11/2025 | 0.31% | 48,589,896 | 152,458 | 51,670 | 2.95 | |
IPHA | Innate Pharma S.A. ADS | 01/15/2025 | 01/27/2025 | 0.22% | 48,589,896 | 105,426 | 46,080 | 2.29 | |
IPHA | Innate Pharma S.A. ADS | 12/31/2024 | 01/10/2025 | 0.21% | 48,589,896 | 101,041 | 150,827 | 1 | |
IPHA | Innate Pharma S.A. ADS | 12/13/2024 | 12/24/2024 | 1.91% | 47,561,816 | 909,824 | 2,774,442 | 1 | |
IPHA | Innate Pharma S.A. ADS | 11/29/2024 | 12/10/2024 | 0.14% | 45,728,917 | 62,946 | 17,546 | 3.59 | |
IPHA | Innate Pharma S.A. ADS | 11/15/2024 | 11/26/2024 | 0.14% | 45,728,917 | 63,718 | 6,177 | 10.32 | |
IPHA | Innate Pharma S.A. ADS | 10/31/2024 | 11/11/2024 | 0.14% | 45,728,917 | 65,217 | 13,338 | 4.89 | |
IPHA | Innate Pharma S.A. ADS | 10/15/2024 | 10/24/2024 | 0.13% | 45,728,917 | 58,785 | 7,703 | 7.63 | |
IPHA | Innate Pharma S.A. ADS | 09/30/2024 | 10/09/2024 | 0.16% | 45,728,917 | 71,841 | 10,796 | 6.65 | |
IPHA | Innate Pharma S.A. ADS | 09/13/2024 | 09/24/2024 | 0.13% | 45,728,917 | 59,736 | 5,623 | 10.62 | |
IPHA | Innate Pharma S.A. ADS | 08/30/2024 | 09/11/2024 | 0.14% | 45,728,917 | 65,131 | 6,696 | 9.73 | |
IPHA | Innate Pharma S.A. ADS | 08/15/2024 | 08/26/2024 | 0.15% | 45,728,917 | 66,826 | 5,031 | 13.28 | |
IPHA | Innate Pharma S.A. ADS | 07/31/2024 | 08/09/2024 | 0.14% | 45,728,917 | 64,466 | 3,749 | 17.2 | |
IPHA | Innate Pharma S.A. ADS | 07/15/2024 | 07/24/2024 | — | — | 72,858 | 8,751 | 8.33 | |
IPHA | Innate Pharma S.A. ADS | 06/28/2024 | 07/10/2024 | — | — | 69,301 | 12,905 | 5.37 | |
IPHA | Innate Pharma S.A. ADS | 06/14/2024 | 06/26/2024 | — | — | 72,934 | 7,853 | 9.29 | |
IPHA | Innate Pharma S.A. ADS | 05/31/2024 | 06/11/2024 | — | — | 70,004 | 13,579 | 5.16 | |
IPHA | Innate Pharma S.A. ADS | 05/15/2024 | 05/24/2024 | — | — | 70,166 | 3,757 | 18.68 | |
IPHA | Innate Pharma S.A. ADS | 04/30/2024 | 05/09/2024 | — | — | 79,102 | 6,113 | 12.94 | |
IPHA | Innate Pharma S.A. ADS | 04/15/2024 | 04/24/2024 | — | — | 81,275 | 15,432 | 5.27 | |
IPHA | Innate Pharma S.A. ADS | 03/28/2024 | 04/09/2024 | — | — | 76,869 | 10,235 | 7.51 | |
IPHA | Innate Pharma S.A. ADS | 03/15/2024 | 03/26/2024 | — | — | 89,075 | 12,353 | 7.21 | |
IPHA | Innate Pharma S.A. ADS | 02/29/2024 | 03/11/2024 | — | — | 78,358 | 3,939 | 19.89 | |
IPHA | Innate Pharma S.A. ADS | 02/15/2024 | 02/27/2024 | — | — | 82,363 | 7,836 | 10.51 | |
IPHA | Innate Pharma S.A. ADS | 01/31/2024 | 02/09/2024 | — | — | 75,951 | 9,715 | 7.82 | |
IPHA | Innate Pharma S.A. ADS | 01/12/2024 | 01/24/2024 | — | — | 76,672 | 18,925 | 4.05 | |
IPHA | Innate Pharma S.A. ADS | 12/29/2023 | 01/10/2024 | — | — | 84,218 | 66,298 | 1.27 | |
IPHA | Innate Pharma S.A. ADS | 12/15/2023 | 12/27/2023 | — | — | 54,024 | 12,370 | 4.37 | |
IPHA | Innate Pharma S.A. ADS | 11/30/2023 | 12/11/2023 | — | — | 57,420 | 3,423 | 16.77 | |
IPHA | Innate Pharma S.A. ADS | 11/15/2023 | 11/27/2023 | — | — | 60,030 | 29,105 | 2.06 | |
IPHA | Innate Pharma S.A. ADS | 10/31/2023 | 11/09/2023 | — | — | 63,748 | 8,094 | 7.88 |
En busca de los valores más cortos?